- ￥1568 - 5790
- MedChemExpress(MCE)
- 美国
- HY-15369
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
902779-59-3
- 规格：
1 mg/5 mg/10 mg
| 规格： | 1 mg | 产品价格： | ￥1568.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥3450.0 |
| 规格： | 10 mg | 产品价格： | ￥5790.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
FPA-124
CAS No. : 902779-59-3
MCE 国际站：FPA-124
产品活性：FPA-124，一种细胞通透性铜配合物，是选择性的 Akt 抑制剂，IC50 为 0.1 μM ，与 Akt 的蛋白同源性 (PH) 域和激酶结构域相互作用。FPA-124 诱导细胞凋亡 (apoptosis)。
研究领域：PI3K/Akt/mTOR | Apoptosis
In Vitro: FPA-124 exhibits dose-dependent growth inhibitory effects with IC50s of 7, 10, 34, and 55 μM in BT20, PC-3, COLO 357 and BxPC-3 cancer cell lines, respectively.
In Vivo: FPA-124 exhibits PKB (Akt protein) inhibitory activities and causes NF-κB inactivation in a well-established orthotopic pancreatic tumor model using COLO 357 cells.
相关产品：Bioactive Compound Library Plus | Apoptosis Compound Library | Kinase Inhibitor Library | PI3K/Akt/mTOR Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Oxygen Sensing Compound Library | Glycolysis Compound Library | Cytoskeleton Compound Library | Glutamine Metabolism Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Glucose Metabolism Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Cancer Stem Cells Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | Highly Selective Activators Library | Cell Death Library | Serine/Threonine Kinase Inhibitor Library | MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Monomethyl auristatin E
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验的维生素 D 状态是否与新冠检测阳性相关，并控制了人口统计学和共病指标。 其中，124 名参与者（25%）显示维生素 D 含量不足，287 名参与者（59%）维生素 D 含量充足。统计结果发现缺乏维生素 D 的人感染新冠的风险，比维生素 D 充足的人高出近两倍。 图 1：来源 JAMA Network Open 补充维生素 D，可降低新冠感染风险、改善新冠感染者的病情 2020 年 11 月，发表在 Postgrad Med J 杂志上的一项研究 Short term, high
( 8 ), two NF-AT sites at positions −292 to −255 ( 9 ), a USF site at positions −159 to −173 ( 10 – 12 ), a TCF-lα site at positions −139 to −124 ( 13 ), and two NF-kB enhancer elements at positions −104 to −81
/(FileDownload)?OpenAgent&docid=87478CFA7E09E0C7C1256EB400417E59&file=18115758.pdf 蛋白质纯化手册(98页) http://www5.amershambiosciences.com/aptrix/upp00919.nsf/(FileDownload)?OpenAgent&docid=9C7BA3DA6539F07AC1256EB40044A8B2&file=18113229AC.pdf 凝胶过滤原理和方法(124页) http
技术资料暂无技术资料 索取技术资料
